Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study.
Jacques-Emmanuel SaadounHélène MeillatChristophe ZemmourSerge BrunelleAlexandra LapeyreCécile de ChaisemartinBernard LelongPublished in: BJS open (2022)
Our nomogram is a simple tool for predicting cancer recurrence in patients with locally advanced rectal cancer after neoadjuvant CRT followed by TME. It provides an individual risk prediction of recurrence to tailor surveillance.
Keyphrases
- rectal cancer
- locally advanced
- neoadjuvant chemotherapy
- phase ii study
- free survival
- lymph node metastasis
- papillary thyroid
- minimally invasive
- squamous cell carcinoma
- radiation therapy
- public health
- coronary artery bypass
- stem cells
- squamous cell
- coronary artery disease
- bone marrow
- lymph node
- percutaneous coronary intervention
- cell therapy
- mesenchymal stem cells
- atrial fibrillation